Anadolu Medical Center
Anadolu Medical Center
Turquie, Istanbul
Zafer Gulbas
49 années d'expérience • + de 3315 traitements effectués
accréditations :
La clinique est certifiée :
| Turquie | Espagne | Allemagne | |
| Typage HLA | de $200 | de $200 | de $600 |
Bookimed ne facture pas de frais supplémentaires pour les prix des Typage HLA. Les tarifs sont issus des listes de prix officielles des cliniques. Vous payez directement à la clinique lors de votre arrivée pour votre Typage HLA.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans Typage HLA et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de Typage HLA.
Le professeur MD Zafer Gulbas est spécialiste en oncologie médicale et hématologie, directeur de l'oncologie médicale au centre médical Anadolu et fondateur du centre de transplantation de moelle osseuse à Anadolu. Il est un hématologue-oncologue hautement qualifié, spécialisé dans la greffe de moelle osseuse, diplômé de la faculté de médecine de l'université Hacettepe, de la faculté de médecine de l'université d'Anadolu, du centre des maladies pulmonaires et de chirurgie thoracique d'Atatürk, du centre médical Hadassah, du centre de recherche sur le cancer Fred Hutchinson, du centre de recherche sur le cancer MDAnderson. et l'hôpital Princess Margaret de l'Université de Toronto.
Dr. Ceyhun Bozkurt is a pediatric hematologist-oncologist at Medical Park Bahcelievler Hospital. He serves as the clinical director and vice director of the stem cell transplant unit. Dr. Bozkurt focuses on childhood leukemia, bone marrow transplants, and neuroblastoma. He completed specialized observerships at Harvard University and Cincinnati Children's Hospital.
Dr. Bülent Ünal is a general surgeon and surgical oncologist. He is Head of General Surgery and Surgical Oncology at Florence Nightingale Hospital. He graduated from Çukurova University in 1996. He completed his general surgery residency at Ankara Numune Training and Research Hospital in 2001. He finished a minor specialization in surgical oncology at İnönü University in 2012.
In 2008, he was an NCI Short-Term Scientist at the University of Pittsburgh Medical Center for 10 months. He trained in sentinel node techniques and ductoscopy. In 2010, he completed transplantation and oncology training at the University of Giessen and Marburg. He has many international publications and book chapters. His co-authored series include 128 living-donor liver recipients, 26 Fournier gangrene cases, and 18 diaphragmatic injuries.
He serves on the Board of the Surgical Oncology Association. He is also a member of several Turkish and international surgical societies.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.